1. Response to Comment on Francés et al. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance. Diabetes 2015;64:1522–1531
   Ángela M. Valverde et al, 2015, Diabetes CrossRef
2. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver
   Yutaka Takahashi, 2017, International Journal of Molecular Sciences CrossRef
3. Cellular Senescence and Their Role in Liver Metabolism in Health and Disease: Overview and Future Directions
   Matthew Schade et al, 2018, Hepatocellular Carcinoma - Advances in Diagnosis and Treatment CrossRef
4. Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma
   Mengna Wu et al, 2020, Current Molecular Pharmacology CrossRef
5. Influence of 3D Microgrooves on C2C12 Cell Proliferation, Migration, Alignment, F-actin Protein Expression and Gene Expression
   Huichang Gao et al, 2016, Journal of Materials Science & Technology CrossRef
6. Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
   Alessandra Caligiuri et al, 2021, Cells CrossRef
7. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
   Devaraj Ezhilarasan et al, 2018, Hepatobiliary & Pancreatic Diseases International CrossRef
8. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice
   Omar Motiño et al, 2016, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
9. Inhibition of pro-collagen I expression by oxymatrine in hepatic stellate cells is mediated via nuclear translocation of Y-box binding protein 1
   MEILING DU et al, 2015, Molecular Medicine Reports CrossRef
10. Cellular senescence and liver disease: Mechanisms and therapeutic strategies
    Mei Guo, 2017, Biomedicine & Pharmacotherapy CrossRef
11. Nanotechnology-based combinational strategies toward the regulation of myofibroblasts and diseased microenvironment in liver fibrosis and hepatic carcinoma
    Fenfen Li et al, 2023, Nano Research CrossRef
12. Hepatic stellate cells as key target in liver fibrosis
    Takaaki Higashi et al, 2017, Advanced Drug Delivery Reviews CrossRef
13. Reversal of liver fibrosis: From fiction to reality
    Miguel Eugenio Zoubek et al, 2017, Best Practice & Research Clinical Gastroenterology CrossRef
14. Effect of celecoxib against different developmental stages of experimental Schistosoma mansoni infection
    Iman Fathy Abou-El-Naga et al, 2021, Acta Tropica CrossRef
15. The potential role of senescence in limiting fibrosis caused by aging
    Xinghua Meng et al, 2020, Journal of Cellular Physiology CrossRef
16. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
    Cyril Sobolewski et al, 2021, Biomolecules CrossRef
17. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
    Yau-Tuen Chan et al, 2020, Frontiers in Pharmacology CrossRef
18. Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis
    Jaiwoo Lee et al, 2022, Nature Communications CrossRef